US 12,171,568 B2
Neurofeedback and induction of an immune response
Talma Hendler, Tel Aviv (IL); Asya Rolls, Haifa (IL); Nitzan Lubianiker, Haifa (IL); Tamar Koren, Haifa (IL); Neomi Singer, Givatayim (IL); Tamar Ben Shannan, Haifa (IL); Shai Shen Orr, Karkur (IL); Fahed Hakim, Nazareth (IL); Hilla Azulay-Debby, Nazareth (IL); and Rani Cohen, Haifa (IL)
Assigned to TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, Haifa (IL); ICHILOV TECH LTD., Tel Aviv (IL); and RAMOT AT TEL-AVIV UNIVERSITY LTD., Tel Aviv (IL)
Appl. No. 17/435,906
Filed by TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, Haifa (IL); ICHILOV TECH LTD., Tel Aviv (IL); and RAMOT AT TEL-AVIV UNIVERSITY LTD., Tel Aviv (IL)
PCT Filed Mar. 3, 2020, PCT No. PCT/IL2020/050240
§ 371(c)(1), (2) Date Sep. 2, 2021,
PCT Pub. No. WO2020/178820, PCT Pub. Date Sep. 10, 2020.
Claims priority of provisional application 62/813,059, filed on Mar. 3, 2019.
Prior Publication US 2022/0151542 A1, May 19, 2022
Int. Cl. A61B 5/00 (2006.01); A61B 5/055 (2006.01); A61B 5/378 (2021.01); A61B 10/00 (2006.01)
CPC A61B 5/411 (2013.01) [A61B 5/055 (2013.01); A61B 5/378 (2021.01); A61B 5/4833 (2013.01); A61B 5/486 (2013.01); A61B 10/0035 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A method for increasing vaccination efficacy in a subject administered therewith, comprising the step of activating a mesolimbic neuron in said subject by applying a neurofeedback prior to vaccination of said subject, thereby increasing the vaccination efficacy in the vaccinated subject.